GlobeNewsWire
25 Feb 2026, 21:01 UTC · 29w ago
Verdict
Headline takes no side. We score DORM +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 74% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Dorman Products projects 2026 net sales growth of 7% to 9% and adjusted diluted EPS between $8.10 and $8.50.
So whatPositive forward-looking guidance for both revenue and earnings generally drives stock price appreciation.
More positive than 91% of claims this week
Full year 2025 adjusted diluted EPS grew by 24% to $8.87, while net sales increased by 6% to $2,130.3 million.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 76% of claims this week
Fourth quarter 2025 diluted EPS dropped 79% to $0.38 due to a non-cash goodwill impairment in the Heavy Duty segment.
So whatWhile non-cash, an impairment indicates a decline in the valuation of a business segment, reflecting internal performance or market headwinds.
More negative than 73% of claims this week
The company's 2026 guidance is contingent on the timing of tariff pricing and assumes no net change following the Supreme Court’s IEEPA tariff ruling.
More negative than 63% of claims this week
Which stocks this story touches
More positive than 74% of ticker scores this week
The company reported strong full-year growth in net sales and adjusted EPS, and issued positive guidance for 2026.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Accesswire
1d ago
+6.9%
Price agrees with the score
$122.44 vs $114.50 close before publication (Feb 25) · not market-adjusted
DORM chart →
